Literature DB >> 23494409

High prevalence of vertebral fractures assessed by quantitative morphometry in hemodialysis patients, strongly associated with vascular calcifications.

Maria Fusaro1, Giovanni Tripepi, Marianna Noale, Nicola Vajente, Mario Plebani, Martina Zaninotto, Giuseppe Guglielmi, Diego Miotto, Luca Dalle Carbonare, Angela D'Angelo, Daniele Ciurlino, Riccarda Puggia, Davide Miozzo, Sandro Giannini, Maurizio Gallieni.   

Abstract

Few studies have provided information on the prevalence of vertebral fractures (VFs) and their risk factors in hemodialysis patients. A multicenter, cross-sectional, observational study was carried out to assess the prevalence of VFs and vascular calcifications (VCs) in 387 hemodialysis patients (mean age 64.2 ± 14.1 years, 63 % males) and in a control group of 51 osteoporotic subjects. Biochemical tests included 25(OH) vitamin D, bone Gla protein (total and undercarboxylated), and total matrix Gla protein. Vertebral quantitative morphometry was carried out centrally for the detection of VF, defined as reduction by ≥20 % of one of the vertebral body dimensions. In the same radiograph, aortic and iliac VC scores were calculated. Prevalence of VF was 55.3 % in hemodialysis patients and 51.0 % in the control group. Multivariate analysis disclosed that male gender (59.8 vs. 47.6 %, p = 0.02; OR = 1.78, 95 % CI 1.15-2.75) and age (mean ± SD 66.7 ± 13.1 vs. 61.0 ± 14.7 years, p < 0.001; OR = 1.03, 95 % CI 1.01-1.05) were significantly associated with VF. The prevalence of aortic VC was significantly higher in hemodialysis patients than in controls (80.6 vs. 68.4 %, p = 0.001). The factors with the strongest association with VC, apart from atrial fibrillation, were serum 25(OH)vitamin D levels below 29 ng/mL for aortic VC (OR = 1.85, 95 % CI 1.04-3.29) and VF both for aortic (OR = 1.77, 95 % CI 1.00-3.14) and iliac (OR = 1.96, 95 % CI 1.27-3.04) VC. In conclusion, the prevalence of VF, especially in males, and VC, in both genders, is high in hemodialysis patients. VF is associated with VC. Vitamin D deficiency is also associated with VC. Further longitudinal studies are warranted to investigate fractures in renal patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23494409     DOI: 10.1007/s00223-013-9722-x

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  17 in total

1.  Bone fracture risk factors in prevalent hemodialysis patients.

Authors:  Patrícia João Matias; Ivo Laranjinha; Ana Azevedo; Ana Raimundo; David Navarro; Cristina Jorge; Inês Aires; Marco Mendes; Carina Ferreira; Tiago Amaral; Célia Gil; Aníbal Ferreira
Journal:  J Bone Miner Metab       Date:  2019-09-05       Impact factor: 2.626

Review 2.  Management of osteoporosis in patients with chronic kidney disease.

Authors:  M Abdalbary; M Sobh; S Elnagar; M A Elhadedy; N Elshabrawy; M Abdelsalam; K Asadipooya; A Sabry; A Halawa; A El-Husseini
Journal:  Osteoporos Int       Date:  2022-06-24       Impact factor: 5.071

3.  Evaluation of bone densitometry by dual-energy x-ray absorptiometry as a fracture prediction tool in women with chronic kidney disease.

Authors:  Valeria E Gómez-Islas; Kevin R García-Fong; Rosa E Aguilar-Fuentes; Salvador Hernández-Castellanos; Alfredo Pherez-Farah; Sofía A Méndez-Bribiesca; Juan M López-Navarro; Hillary K Osorio-Landa; Sergio L Carbajal-Morelos; Areli M Zúñiga-Guzmán; Iván Pérez-Díaz
Journal:  Bone Rep       Date:  2020-07-18

4.  Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.

Authors:  M Atteritano; E Di Mauro; V Canale; A M Bruzzese; C A Ricciardi; V Cernaro; A Lacquaniti; M Buemi; D Santoro
Journal:  Osteoporos Int       Date:  2016-09-28       Impact factor: 4.507

5.  The utility of FRAX® in predicting bone fractures in patients with chronic kidney disease on hemodialysis: a two-year prospective multicenter cohort study.

Authors:  J Przedlacki; J Buczyńska-Chyl; P Koźmiński; E Niemczyk; E Wojtaszek; E Gieglis; P Żebrowski; A Podgórzak; J Wściślak; M Wieliczko; J Matuszkiewicz-Rowińska
Journal:  Osteoporos Int       Date:  2018-02-06       Impact factor: 4.507

6.  Mortality and complications after hip fracture among elderly patients undergoing hemodialysis.

Authors:  Jeff Chien-Fu Lin; Wen-Miin Liang
Journal:  BMC Nephrol       Date:  2015-07-07       Impact factor: 2.388

Review 7.  Chronic kidney disease and fragility fracture.

Authors:  Junichiro James Kazama
Journal:  Clin Exp Nephrol       Date:  2016-12-23       Impact factor: 2.801

8.  Trabecular bone score may indicate chronic kidney disease-mineral and bone disorder (CKD-MBD) phenotypes in hemodialysis patients: a prospective observational study.

Authors:  Hyo Jin Yun; Soo Ryeong Ryoo; Jung-Eun Kim; Yong Jun Choi; Inwhee Park; Gyu-Tae Shin; Heungsoo Kim; Jong Cheol Jeong
Journal:  BMC Nephrol       Date:  2020-07-25       Impact factor: 2.388

9.  A microRNA Approach to Discriminate Cortical Low Bone Turnover in Renal Osteodystrophy.

Authors:  Thomas L Nickolas; Neal Chen; Donald J McMahon; David Dempster; Hua Zhou; James Dominguez; Maria A Aponte; Joshua Sung; Pieter Evenepoel; Patrick C D'Haese; Fabrice Mac-Way; Rosa Moyses; Sharon Moe
Journal:  JBMR Plus       Date:  2020-03-25

10.  Bone turnover correlates with bone quantity but not bone microarchitecture in chronic hemodialysis.

Authors:  Roxana Dusceac; Dan Alexandru Niculescu; Ramona Dobre; Madalina Cristina Sorohan; Andra Caragheorgheopol; Catalin Tacu; Cristiana David; Catalina Poiana
Journal:  J Bone Miner Metab       Date:  2020-03-06       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.